World's Best Scientists 2026 revealed!
Award Badge
Medicine
France
2023

D-Index & Metrics

Medicine

D-Index
139
Citations
61271
World Ranking
1776
National Ranking
46

Research.com Recognitions

  • 2023 - Research.com Medicine in France Leader Award

Overview

Philippe Ravaud is affiliated with Université Paris Cité in France and has a substantial publication record primarily in the field of Medicine. Their research covers a variety of subfields including Public Health, Environmental and Occupational Health, Statistics, Probability and Uncertainty, Infectious Diseases, Economics and Econometrics, and Neurology.

Their main research topics include meta-analysis and systematic reviews, health systems, economic evaluations, quality of life, long-term effects of COVID-19, COVID-19 clinical research studies, ethics in clinical research, SARS-CoV-2 and COVID-19 research, and the Delphi technique in research.

Notable recent papers authored or co-authored by Philippe Ravaud include:

  • Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia (2020), published in JAMA Internal Medicine
  • Clinical efficacy of hydroxychloroquine in patients with covid-19 pneumonia who require oxygen: observational comparative study using routine care data (2020), published in BMJ
  • Efficacy and safety of COVID-19 vaccines (2022), published in Cochrane Database of Systematic Reviews
  • Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial (2021), published in The Lancet Respiratory Medicine
  • Course of post COVID-19 disease symptoms over time in the ComPaRe long COVID prospective e-cohort (2022), published in Nature Communications

Frequent co-authors collaborating with Philippe Ravaud include:

  • Isabelle Boutron
  • Asbjørn Hróbjartsson
  • Joerg J Meerpohl
  • David Tovey
  • Anna Chaimani

The scientist has published extensively in recognized venues, with the most frequent being:

  • Zenodo (CERN European Organization for Nuclear Research)
  • Journal of Clinical Epidemiology
  • BMJ
  • OPAL (Open@LaTrobe) (La Trobe University)
  • bioRxiv (Cold Spring Harbor Laboratory)

Best Publications

  • A prospective survey of patients with valvular heart disease in Europe : The Euro Heart Survey on Valvular Heart Disease.

    Bernard Iung;Gabriel Baron;Eric G. Butchart;François Delahaye

  • Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration.

    Isabelle Boutron;David Moher;Douglas G Altman;Kenneth F Schulz

  • Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery?

    Bernard Iung;Agnès Cachier;Gabriel Baron;David Messika-Zeitoun

  • Evaluation of clinically relevant changes in patient reported outcomes in knee and hip osteoarthritis: the minimal clinically important improvement

    F Tubach;P Ravaud;G Baron;B Falissard

  • CONSORT Statement for Randomized Trials of Nonpharmacologic Treatments: A 2017 Update and a CONSORT Extension for Nonpharmacologic Trial Abstracts

    Isabelle Boutron;Douglas G Altman;David Moher;Kenneth F Schulz

  • Rituximab versus Azathioprine for Maintenance in ANCA-Associated Vasculitis

    Loïc Guillevin;Christian Pagnoux;Alexandre Karras;Chahera Khouatra

  • Artificial intelligence in health care: value for whom?

    Jean-David Zeitoun;Philippe Ravaud;Philippe Ravaud

  • What are the characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery?

    Mariana Mirabel;Bernard Iung;Gabriel Baron;David Messika-Zeitoun

  • EULAR Sjögren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjögren's syndrome

    Raphaele Seror;Philippe Ravaud;Simon J. Bowman;Gabriel Baron

  • Risk of tuberculosis is higher with anti–tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three‐year prospective french research axed on tolerance of biotherapies registry

    Florence Tubach;Dominique Salmon;Philippe Ravaud;Yannick Allanore

  • Reporting and interpretation of randomized controlled trials with statistically nonsignificant results for primary outcomes.

    Isabelle Boutron;Susan Dutton;Philippe Ravaud;Douglas G. Altman

  • Comparison of registered and published primary outcomes in randomized controlled trials.

    Sylvain Mathieu;Isabelle Boutron;David Moher;Douglas G. Altman

  • High-dose therapy and autologous peripheral blood stem cell transplantation in multiple myeloma: up-front or rescue treatment? Results of a multicenter sequential randomized clinical trial.

    Jean-Paul Fermand;Philippe Ravaud;Sylvie Chevret;Marine Divine

  • Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia: A Randomized Clinical Trial.

    Olivier Hermine;Olivier Hermine;Xavier Mariette;Pierre-Louis Tharaux;Matthieu Resche-Rigon

  • Evaluation of clinically relevant states in patient reported outcomes in knee and hip osteoarthritis: the patient acceptable symptom state

    F Tubach;P Ravaud;G Baron;B Falissard

  • Infective endocarditis in Europe: lessons from the Euro heart survey

    P Tornos;B Iung;G Permanyer-Miralda;G Baron

  • Methods and Processes of the CONSORT Group: Example of an Extension for Trials Assessing Nonpharmacologic Treatments

    Isabelle Boutron;David Moher;Douglas G Altman;Kenneth F Schulz

  • High-Dose Therapy and Autologous Blood Stem-Cell Transplantation Compared With Conventional Treatment in Myeloma Patients Aged 55 to 65 Years: Long-Term Results of a Randomized Control Trial From the Group Myelome-Autogreffe

    Jean-Paul Fermand;Sandrine Katsahian;Marine Divine;Veronique Leblond

  • Inefficacy of infliximab in primary Sjögren's syndrome: results of the randomized, controlled Trial of Remicade in Primary Sjögren's Syndrome (TRIPSS).

    Xavier Mariette;Philippe Ravaud;Serge Steinfeld;Gabriel Baron

  • Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: Explanation and elaboration

    I Boutron;D Moher;D G Altman;K F Schulz

Frequent Co-Authors

Isabelle Boutron
Isabelle Boutron Université Paris Cité
Maxime Dougados
Maxime Dougados Hôpital Cochin
Xavier Mariette
Xavier Mariette University of Paris-Saclay
Raphaël Porcher
Raphaël Porcher Université Paris Cité
Jean Sibilia
Jean Sibilia University of Strasbourg
Xavier Puéchal
Xavier Puéchal Université Paris Cité
Bernard Combe
Bernard Combe University of Montpellier
Bruno Fautrel
Bruno Fautrel Université Paris Cité
Douglas G. Altman
Douglas G. Altman University of Oxford

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering studying Medicine in the USA, there are several online degree options and career pathways worth exploring. For nursing professionals, pursuing an rn to bsn online can be a flexible and affordable route to advancing your qualifications while balancing work and study.

If you hold a non-nursing bachelor’s degree but want to enter the nursing field, direct entry msn programs for non-nursing majors offer a fast-tracked way into advanced nursing roles. There are also options for career changers, as online bsn programs for non nurses can provide a more accessible pathway to starting your nursing journey.

For those interested in the administrative side of healthcare, medical billing and coding schools online with financial aid can help you enter an in-demand career that supports the medical industry behind the scenes.

Each of these online programs is designed to be flexible, helping you balance personal commitments with advancing your education and career in the fast-growing healthcare sector.

Best Scientists Citing Philippe Ravaud

Trending Scientists

Recently Published Articles